School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China.
Division of Orthopedic Surgery, Department of Surgery, Zuoying Branch of Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan, Republic of China.
Analyst. 2022 Dec 5;147(24):5732-5738. doi: 10.1039/d2an01433e.
In this study, a simple and facile procedure using the all or none formation of double-stranded DNA-templated copper nanoclusters on specific-primer PCR fragments was designed to fluorescently identify the T315I single nucleotide variant on the - gene. Chronic myeloid leukaemia (CML), a disease caused by the - fusion of tyrosine kinase, is well known for the T315I mutation that causes tyrosine kinase inhibitors (TKIs) to be resisted due to the alternative structure of the drug-binding site. Therefore, it is an important single nucleotide variant for clinical detection. In this study, only specific functional primers and the digestion of the wild genotype from the T315I mutation site with specific restriction enzymes were designed, and the different digested products could then be captured using magnetic beads. The final products would allow for fluorescent sensing the all or none formation of double-stranded DNA-templated copper nanoclusters for the detection of the T315I mutation. This study has been successfully applied for identifying wild and mutant homozygotes and the mutant/wild heterozygote of the T315I mutation. It is expected that this analytical system can serve as a tool for the clinical diagnosis of T315I mutations and be applied to real samples of CML patients in the future.
在这项研究中,设计了一种简单易行的方法,利用双链 DNA 模板化铜纳米簇在特定引物 PCR 片段上的全有或全无形成来荧光识别 - 基因上的 T315I 单核苷酸变异。慢性髓性白血病(CML)是一种由酪氨酸激酶融合引起的疾病,其 T315I 突变导致酪氨酸激酶抑制剂(TKI)产生耐药性,因为药物结合位点的结构发生了改变,因此,T315I 突变是临床检测的一个重要单核苷酸变异。在这项研究中,仅设计了特定功能的引物和从 T315I 突变位点用特定的限制酶对野生型进行消化,然后可以使用磁珠捕获不同的消化产物。最终产物允许用于荧光检测双链 DNA 模板化铜纳米簇的全有或全无形成,以检测 T315I 突变。这项研究已成功应用于识别 T315I 突变的野生型和突变型纯合子以及突变型/野生型杂合子。预计这个分析系统可以作为 T315I 突变的临床诊断工具,并在未来应用于 CML 患者的实际样本。